Cite
HARVARD Citation
Bunch, B. et al. (2019). TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell cycle. 18 (17), pp. 2055-2066. [Online].